openPR Logo
Press release

Gastrointestinal Anastomosis Market Set to Witness Significant Growth by 2025-2034

08-26-2025 01:27 PM CET | Health & Medicine

Press release from: Exactitude Consultancy

Gastrointestinal Anastomosis Market

Gastrointestinal Anastomosis Market

Introduction
Gastrointestinal (GI) anastomosis is a critical surgical procedure involving the connection of two segments of the digestive tract, performed after resections for conditions such as cancer, bowel obstruction, Crohn's disease, ulcerative colitis, and trauma. The procedure can be performed using surgical staplers, sutures, or advanced minimally invasive devices. With gastrointestinal cancers, inflammatory bowel disease (IBD), and obesity on the rise globally, the demand for GI anastomosis procedures is expanding rapidly.

Advancements in minimally invasive techniques, increased adoption of surgical staplers, and growing investments in healthcare infrastructure are shaping the gastrointestinal anastomosis market. The next decade promises robust growth, supported by both rising surgical volumes and continuous innovation in surgical devices.

Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/71164

Market Overview
• Market Size (2024): Approximately USD 3.6 billion
• Forecast (2034): Approximately USD 7.1 billion
• CAGR (2025-2034): 7.0%

Growth Drivers:
• Rising prevalence of gastrointestinal cancers and IBD.
• Increasing bariatric surgeries due to the obesity epidemic.
• Technological advancements in surgical staplers and robotic-assisted systems.
• Expansion of healthcare infrastructure in emerging economies.
• Growing preference for minimally invasive surgeries that reduce hospital stays.

Challenges:
• High cost of advanced surgical devices.
• Post-surgical complications such as leaks and infections.
• Limited access to advanced surgical technologies in low-income regions.

Segmentation Analysis
The gastrointestinal anastomosis market can be segmented as follows:
• By Product Type:
o Surgical Staplers (manual, powered)
o Sutures
o Surgical Sealants and Adhesives
o Other Advanced Devices (robotic-assisted tools)

• By Surgery Type:
o Gastrointestinal Surgery (stomach, intestines)
o Colorectal Surgery
o Bariatric Surgery
o Other GI Procedures (trauma, rare conditions)

• By Technique:
o Handsewn Anastomosis
o Mechanical Anastomosis (staplers, devices)
o Hybrid/Robotic-assisted Anastomosis

• By End Use:
o Hospitals (majority share due to surgical infrastructure)
o Ambulatory Surgical Centers (ASCs)
o Specialty Clinics
o Research and Academic Institutes

Summary: Surgical staplers dominate the product segment, owing to their efficiency, precision, and reduced surgical time. Powered staplers are gaining popularity due to consistent performance. Bariatric surgery and colorectal procedures represent major growth areas, particularly with rising obesity and colorectal cancer rates globally.

Explore Full Report here:
https://exactitudeconsultancy.com/reports/71164/gastrointestinal-anastomosis-market

Regional Analysis
• North America:
The largest market, driven by advanced healthcare infrastructure, high prevalence of obesity and colorectal cancer, and early adoption of robotic-assisted surgical systems. The U.S. leads with widespread use of surgical staplers and minimally invasive procedures.
• Europe:
A strong market, with Germany, the UK, France, and Italy as leading contributors. Europe is notable for its focus on patient safety, regulatory oversight, and widespread use of powered staplers in GI surgeries.
• Asia-Pacific:
Expected to record the fastest CAGR, fueled by growing surgical volumes in India and China, rising obesity rates, and increasing incidence of colorectal and gastric cancers. Japan and South Korea are early adopters of robotic-assisted procedures.
• Middle East & Africa:
A developing market where growing healthcare investment and medical tourism are contributing to gradual expansion. Limited access to advanced devices remains a constraint.
• Latin America:
Brazil, Mexico, and Argentina are leading markets, supported by expanding healthcare reforms and rising adoption of laparoscopic surgeries.

Regional Summary: While North America and Europe dominate current revenues, Asia-Pacific is the growth engine for the future, driven by its large population base, rising GI disease burden, and expanding hospital infrastructure.

Market Dynamics
Key Growth Drivers:
• Increasing incidence of colorectal cancer and IBD worldwide.
• Growth in bariatric surgeries due to obesity epidemic.
• Rising preference for minimally invasive and laparoscopic GI surgeries.
• Technological advancements in surgical staplers and sealants.

Key Challenges:
• Post-surgical complications such as anastomotic leaks.
• High costs of advanced stapling and robotic systems.
• Lack of trained surgeons in developing economies.

Latest Trends:
• Development of powered staplers offering consistency and precision.
• Integration of robotic-assisted systems for enhanced surgical outcomes.
• Expansion of bio-absorbable sealants and adhesives to reduce leakage risks.
• Adoption of AI-assisted surgical planning and training platforms.
• Growing medical tourism in Asia and Latin America for cost-effective GI surgeries.

Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=71164

Competitor Analysis
Key Players:
• Medtronic plc
• Ethicon (Johnson & Johnson)
• B. Braun Melsungen AG
• Conmed Corporation
• Intuitive Surgical Inc.
• Olympus Corporation
• Smith & Nephew plc
• Boston Scientific Corporation
• 3M Company (surgical adhesives)
• Cook Medical

Competitive Landscape:
The market is moderately consolidated, with Medtronic and Ethicon dominating the surgical stapler segment. Intuitive Surgical is a leader in robotic-assisted procedures, while B. Braun and Conmed offer strong portfolios of sutures and surgical tools. Smaller companies are entering with innovations in bio-absorbable sealants and adhesives. Strategic acquisitions, partnerships, and product launches are common strategies shaping the competitive environment.

Conclusion
The Gastrointestinal Anastomosis Market is set for steady growth, fueled by rising GI disorders, expanding bariatric surgeries, and continuous innovation in surgical technologies. From USD 3.6 billion in 2024, the market is projected to nearly double to USD 7.1 billion by 2034, expanding at a CAGR of 7.0%.

Key opportunities include:
• Expanding adoption of powered staplers and robotic-assisted procedures.
• Developing bio-absorbable adhesives and sealants to minimize complications.
• Enhancing surgeon training in emerging economies.
• Leveraging AI and digital technologies for surgical planning and outcomes.

This report is also available in the following languages : Japanese (消化管吻合市場), Korean (위장관 문합술 시장), Chinese (胃肠吻合术市场), French (Marché de l'anastomose gastro-intestinale), German (Markt für gastrointestinale Anastomose), and Italian (Mercato delle anastomosi gastrointestinali), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/71164

Our More Reports:

Phototherapies for Psoriasis Market
https://exactitudeconsultancy.com/reports/71430/phototherapies-for-psoriasis-market

Pruritis Market
https://exactitudeconsultancy.com/reports/71432/pruritis-market

Psoriasis Vulgaris Market
https://exactitudeconsultancy.com/reports/71434/psoriasis-vulgaris-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.

https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
IRFAN TAMBOLI
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gastrointestinal Anastomosis Market Set to Witness Significant Growth by 2025-2034 here

News-ID: 4160087 • Views:

More Releases from Exactitude Consultancy

Chronic Myelomonocytic Leukemia (CMML) Market Growth, Applications, Innovations and Business Outlook by 2034
Chronic Myelomonocytic Leukemia (CMML) Market Growth, Applications, Innovations …
Introduction Chronic Myelomonocytic Leukemia (CMML) is a rare hematologic malignancy characterized by features of both myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs). It is defined by persistent monocytosis in the blood, bone marrow dysplasia, and a variable clinical course that may progress to acute myeloid leukemia (AML). CMML primarily affects elderly patients and is associated with symptoms such as fatigue, anemia, bleeding tendencies, infections, and splenomegaly. Due to its rarity, CMML remains
Diffuse Large B-Cell Lymphoma (DLBCL) Market Growth, Trends, Consumer Demand and Key Opportunities
Diffuse Large B-Cell Lymphoma (DLBCL) Market Growth, Trends, Consumer Demand and …
Introduction Diffuse Large B-Cell Lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma (NHL), accounting for approximately 30-40% of cases globally. It is an aggressive malignancy of B-lymphocytes, typically presenting with rapidly enlarging lymph nodes, fever, weight loss, and night sweats. Despite being a fast-growing cancer, DLBCL is potentially curable in many patients with appropriate therapy. Traditional treatment has centered around R-CHOP chemotherapy (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone), which remains
Non-Alcoholic Steatohepatitis (NASH) Market 2025-2034 Business Outlook, Critical Insight and Growth
Non-Alcoholic Steatohepatitis (NASH) Market 2025-2034 Business Outlook, Critical …
Introduction Non-Alcoholic Steatohepatitis (NASH) is a progressive liver disease that falls under the spectrum of non-alcoholic fatty liver disease (NAFLD). It is characterized by liver fat accumulation, inflammation, and cell damage, which can lead to fibrosis, cirrhosis, liver failure, or hepatocellular carcinoma. Closely tied to obesity, diabetes, and metabolic syndrome, NASH has become a major global health challenge and a focus of pharmaceutical research. Despite affecting millions worldwide, there are limited approved
Gastroesophageal Reflux Disease (GERD) Devices Market Insights and Future Outlook
Gastroesophageal Reflux Disease (GERD) Devices Market Insights and Future Outloo …
Introduction Gastroesophageal Reflux Disease (GERD) is a chronic condition where stomach contents flow back into the esophagus, causing symptoms such as heartburn, regurgitation, chest pain, and, in severe cases, esophagitis or Barrett's esophagus. While medications like proton pump inhibitors (PPIs) are widely used for management, a growing number of patients experience refractory GERD, where pharmacological treatments fail to provide relief. This has accelerated demand for GERD devices, which include endoscopic therapies, implantable

All 5 Releases


More Releases for Anastomosis

Surge In Surgical Procedures Drives Anastomosis Device Market Growth: The Drivin …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Anastomosis Devices Market Size Growth Forecast: What to Expect by 2025? In recent times, there has been robust growth in the size of the anastomosis devices market. The market, which stood at $3.66 billion in 2024, is projected to expand to $3.9 billion in 2025, representing a compound annual
Top Factor Driving Anastomosis Devices Market Growth in 2025: Surge In Surgical …
Which drivers are expected to have the greatest impact on the over the anastomosis devices market's growth? An upward trajectory in surgical operations is predicted to accelerate the expansion of the anastomosis device market. The term, surgical operations, is applied to any medical procedure that necessitates cutting into a patient's body. Anastomosis devices, principally utilized in surgical operations, allow the connection of two parts of the body, like blood vessels or
Anastomosis Device Market worth $4.4 billion by 2027
Browse 289 market data Tables and 42 Figures spread through 305 Pages and in-depth TOC on "Anastomosis Device Market by Product, Surgical Staplers (Manual, Powered), Surgical Sutures (Absorbable, Non-absorbable, Automated), and Surgical Sealants and Adhesives, Application (CVDs, GI Surgeries) and End Users - Global Forecast to 2027 Anastomosis Device Market [https://www.marketsandmarkets.com/Market-Reports/anastomosis-device-market-5343963.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=anastomosisdevicemarket] is projected to grow from USD 3.0 billion in 2022 to USD 4.4 billion by 2027, at a CAGR of
Anastomosis Devices Market
Market Overview: The Global Anastomosis Devices Market achieved a valuation of US$ YY million in 2022 and is poised to reach US$ YY million by 2030, exhibiting a robust CAGR of YY% during the forecast period from 2023 to 2030. Anastomosis devices play a critical role in surgical procedures, facilitating the connection of blood arteries, intestines, or other tubular bodily parts. These anastomoses are essential for healing damaged tissues, restoring blood flow,
Anastomosis Device Market Trends, Growth, Size, Analysis, Outlook by 2028
An exceptional companion Anastomosis Device Market report takes into consideration diverse segments of the market analysis that today's business ask for. The report provides estimations of CAGR values, market drivers and market restraints about the Veterinary Diagnostics industry which are helpful for the businesses in deciding upon numerous strategies. The base year for calculation in the report is taken as 2022 whereas the historic year is 2019 which will tell
Anastomosis Device Market Report Up to 2031
Visiongain has published a new report on Anastomosis Device Market Report to 2031: Forecasts by Type (Surgical Staplers (Manual and Powered), Surgical Sutures (Absorbable Sutures (Synthetic Sutures (Polyglactin 910 Sutures, Poliglecaprone 25 Sutures, Polydioxanone Sutures, Polyglycolic Acid Sutures, and Other Synthetic Sutures), and Natural Sutures), Non-absorbable Sutures (Polypropylene, Nylon, Stainless Steel, and Other Non-absorbable Sutures), Automated Suturing Devices (Disposable and Reusable), Surgical Sealants and Adhesives (Natural/Biological (Fibrin-based, Collagen-based, and Albumin-based)